Having a PhD in Chemistry and subsequently 17 years as a sector focussed Investment Banker, Chris brings an exceptionally strong chemical sector pedigree to Opus. He has an extensive network within the global chemical space, in its broadest definition, and has significant experience advising on complex sell-sides and buy-sides for corporates, family owned companies and Private Equity clients as well as IPOs and leveraged financing.
Chris began his banking career at Deutsche Bank and later Bank of America Merrill Lynch. More recently he led the EMEA Chemical teams of Nomura and The Royal Bank of Canada. Prior to joining Opus in 2019, Chris was Corporate Development Director for Wilmcote Holdings plc, a UK listed acquisition vehicle with the sole purpose of acquiring, and subsequently building via M&A, a chemical platform asset.
Chris has a PhD in Chemistry and MA in Natural Sciences from the University of Cambridge, UK.